Danaher reached a $172.5 million settlement with shareholders who accused the diagnostics and life-sciences company of defrauding them by overstating demand for its equipment as the worst of the COVID-19 pandemic passed. A preliminary settlement was filed on Wednesday with …
Source: Claims Journal